Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity'. Together they form a unique fingerprint.